Drug management of agitation in emergency departments: Theoretical recommendations and studies of practices

被引:12
|
作者
Horn, Mathilde [1 ,2 ]
Vaiva, Guillaume [2 ]
Dumais, Alexandre [1 ]
机构
[1] Univ Montreal, Inst Philippe Pinel Montreal, Inst Univ Sante Mentale Montreal, Montreal, PQ, Canada
[2] Univ Lille Nord France, Lab Neurosci Fonct & Pathol, Ctr Hosp Univ Lille, F-59037 Lille, France
来源
PRESSE MEDICALE | 2015年 / 44卷 / 01期
关键词
DOUBLE-BLIND; PHARMACOLOGICAL MANAGEMENT; RAPID TRANQUILIZATION; RANDOMIZED-TRIAL; HALOPERIDOL; LORAZEPAM; VIOLENT; ANTIPSYCHOTICS; PSYCHIATRY; OLANZAPINE;
D O I
10.1016/j.lpm.2014.04.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Management of agitation is a frequent problematic of emergency departments that often leads to feelings of insecurity among clinicians. There are various practices regarding the drugs to be used in the management of agitations. Guidelines have been proposed by different groups of experts concerning the antipsychotic drugs that should be used for agitations in psychiatric conditions. Nevertheless, there is no clear-cut procedure referring to the utilization of intramuscular drugs in this situation. Moreover, there is no comparison available between the commonly used medications and other drugs, both in terms of superiority of efficacy and tolerance. In order to accurately assess these practices, evaluation protocols must minimize the interference with the service organization and the routine care. Further studies are required in order to develop guidelines about medications that have to be used to handle agitations, which must be based on robust evidence and applicable to emergency services.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 38 条
  • [31] Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007-2018 National Hospital Ambulatory Medical Care Survey Data
    Yang, Seonkyeong
    Orlova, Yulia
    Lipe, Abigale
    Boren, Macy
    Hincapie-Castillo, Juan M.
    Park, Haesuk
    Chang, Ching-Yuan
    Wilson, Debbie L.
    Adkins, Lauren
    Lo-Ciganic, Wei-Hsuan
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [32] Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure
    Hussey, Alexander D.
    Weintraub, Robert G.
    PEDIATRIC DRUGS, 2016, 18 (02) : 89 - 99
  • [33] Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease A Scientific Statement From the American Heart Association
    Wiggins, Barbara S.
    Saseen, Joseph J.
    Page, Robert L., II
    Reed, Brent N.
    Sneed, Kevin
    Kostis, John B.
    Lanfear, David
    Virani, Salim
    Morris, Pamela B.
    CIRCULATION, 2016, 134 (21) : E468 - E495
  • [34] Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication
    Kawahito, Yutaka
    Morinobu, Akio
    Kaneko, Yuko
    Kohno, Masataka
    Hirata, Shintaro
    Kishimoto, Mitsumasa
    Seto, Yohei
    Sugihara, Takahiko
    Tanaka, Eiichi
    Ito, Hiromu
    Kojima, Toshihisa
    Matsushita, Isao
    Nishida, Keiichiro
    Mori, Masaaki
    Murashima, Atsuko
    Yamanaka, Hisashi
    Nakayama, Takeo
    Kojima, Masayo
    Harigai, Masayoshi
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 21 - 35
  • [35] A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis
    Ash, Zoe
    Gaujoux-Viala, Cecile
    Gossec, Laure
    Hensor, Elizabeth M. A.
    FitzGerald, Oliver
    Winthrop, Kevin
    van der Heijde, Desiree
    Emery, Paul
    Smolen, Josef S.
    Marzo-Ortega, Helena
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) : 319 - 326
  • [36] Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development
    Regev, Arie
    Avigan, Mark, I
    Kiazand, Alexandre
    Vierling, John M.
    Lewis, James H.
    Omokaro, Stephanie O.
    Di Bisceglie, Adrian M.
    Fontana, Robert J.
    Bonkovsky, Herbert L.
    Freston, James W.
    Uetrecht, Jack P.
    Miller, Ethan D.
    Pehlivanov, Nonko D.
    Haque, Syed Asif
    Harrison, Melanie J.
    Kullak-Ublick, Gerd A.
    Li, Hewei
    Patel, Niti N.
    Patwardhan, Meenal
    Price, Karen D.
    Watkins, Paul B.
    Chalasani, Naga P.
    JOURNAL OF AUTOIMMUNITY, 2020, 114
  • [37] Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis
    Regev, Arie
    Palmer, Melissa
    Avigan, Mark I.
    Dimick-Santos, Lara
    Treem, William R.
    Marcinak, John F.
    Seekins, Daniel
    Krishna, Gopal
    Anania, Frank A.
    Freston, James W.
    Lewis, James H.
    Sanyal, Arun J.
    Chalasani, Naga
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (06) : 702 - 713
  • [38] Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management With an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both
    Pollack, Charles V., Jr.
    Diercks, Deborah B.
    Thomas, Stephen H.
    Shapiro, Nathan I.
    Fanikos, John
    Mace, Sharon E.
    Rafique, Zubaid
    Todd, Knox H.
    ACADEMIC EMERGENCY MEDICINE, 2016, 23 (03) : 331 - 341